Eve A. Kerr, MD, MPH; Brian J. Zikmund-Fisher, PhD; Mandi L. Klamerus, MPH; Usha Subramanian, MD, MS; Mary M. Hogan, PhD, RN; Timothy P. Hofer, MD, MS
Clinicians often fail to intensify antihypertensive therapy when their patient's blood pressure is elevated. Kerr and colleagues sought the reasons for this practice by studying 1169 diabetic patients with elevated triage blood pressure during routine primary care visits at 9 Veterans Affairs facilities. Half of the patients did not have an increase in antihypertensive drug dosage, which was associated with patient reports of taking their blood pressure at home, rechecking the blood pressure during the clinical visit, and discussing of antihypertensive medication. Uncertainty about the patient's true blood pressure may contribute to failure to intensify antihypertensive therapy.
Ann Intern Med. 2008;148(10):717-727. doi:10.7326/0003-4819-148-10-200805200-00004
Pragna Patel, MD, MPH; Debra L. Hanson, MS; Patrick S. Sullivan, DVM, PhD; Richard M. Novak, MD; Anne C. Moorman, BSN, MPH; Tony C. Tong, MS; Scott D. Holmberg, MD, MPH; John T. Brooks, MD; for the Adult and Adolescent Spectrum of Disease Project and HIV Outpatient Study Investigators
Antiretroviral therapy has dramatically improved survival of HIV-infected individuals and reduced the incidence of AIDS-defining cancer but may have—directly or indirectly—increased cases of non–AIDS-defining cancer. Patel and associates measured cancer incidence in HIV-infected persons and in the general population. The incidence of several types of non–AIDS-defining cancer was significantly higher in the HIV-infected population.
Ann Intern Med. 2008;148(10):728-736. doi:10.7326/0003-4819-148-10-200805200-00005
Kerri Cavanaugh, MD, MHS; Mary Margaret Huizinga, MD, MPH; Kenneth A. Wallston, PhD; Tebeb Gebretsadik, MPH; Ayumi Shintani, PhD, MPH; Dianne Davis, RD, CDE; Rebecca Pratt Gregory, RD, CDE; Lynn Fuchs, PhD; Robb Malone, PharmD, CDE; Andrea Cherrington, MD, MPH; Michael Pignone, MD, MPH; Darren A. DeWalt, MD, MPH; Tom A. Elasy, MD, MPH; Russell L. Rothman, MD, MPP
We do not understand the influence of a patient's skill with numbers (also called numeracy) on their management of diabetes. Cavanaugh and colleagues tested the ability of 398 adult patients with type 1 or type 2 diabetes to perform tasks related to diabetes care that require calculations or interpretation of numerical results (diabetes-related numeracy). Poor numeracy skills were common, and low diabetes-related numeracy was associated with worse perceived self-efficacy, fewer diabetes self-management behaviors, and possibly poorer glycemic control.
Ann Intern Med. 2008;148(10):737-746. doi:10.7326/0003-4819-148-10-200805200-00006
Hau Liu, MD, MBA, MPH; Dena M. Bravata, MD, MS; Ingram Olkin, PhD; Anne Friedlander, PhD; Vincent Liu, MD; Brian Roberts, MD; Eran Bendavid, MD, MPH; Olga Saynina, MA, MBA; Shelley R. Salpeter, MD; Alan M. Garber, MD, PhD; Andrew R. Hoffman, MD
Athletes have reportedly used human growth hormone to improve performance, but its safety and performance-enhancing efficacy are poorly understood. Liu and colleagues reviewed 44 trials that compared growth hormone treatment with no growth hormone treatment in community-dwelling healthy participants age 13 to 45 years. Lean body mass increased more in growth hormone recipients than nonrecipients, but strength and exercise capacity did not improve. Growth hormone recipients were more likely to have soft tissue edema and fatigue. The authors conclude that the evidence does not support claims that growth hormone enhances physical performance.
Ann Intern Med. 2008;148(10):747-758. doi:10.7326/0003-4819-148-10-200805200-00215
U.S. Preventive Services Task Force
In this update of a 2003 recommendation, the U.S. Preventive Services Task Force concludes that the current evidence is insufficient to assess the balance of benefits and harms of routine screening for gestational diabetes mellitus, either before or after 24 weeks' gestation.
Ann Intern Med. 2008;148(10):759-765. doi:10.7326/0003-4819-148-10-200805200-00008
Teresa A. Hillier, MD, MS; Kimberly K. Vesco, MD, MPH; Kathryn L. Pedula, MS; Tracy L. Beil, MS; Evelyn P. Whitlock, MD, MPH; David J. Pettitt, MD
To support the updated U.S. Preventive Services Task Force recommendation in this issue, Hillier and colleagues reviewed the evidence on the benefits and harms of screening for gestational diabetes mellitus. They found no randomized, controlled trials that directly evaluated the risks and benefits, limited evidence suggesting that treatment after 24 weeks' gestation improves some maternal and neonatal outcomes, and very limited evidence about early screening before 24 weeks' gestation.
Ann Intern Med. 2008;148(10):766-775. doi:10.7326/0003-4819-148-10-200805200-00009
Evelyn P. Whitlock, MD, MPH; Jennifer S. Lin, MD; Roger Chou, MD; Paul Shekelle, MD, PhD; Karen A. Robinson, MSc
Often the only way to answer a clinical question (for example, whether prostate cancer screening reduces cancer-related mortality) is to deconstruct the question into linked subquestions (for example, whether screening detects early cancer; whether early treatment affects mortality). Systematic reviews to support clinical practice guideline development or health policy decision making must often evaluate several linked clinical questions (complex reviews). To reduce the work required for a complex review, authors often use existing systematic reviews. Whitlock and colleagues discuss the methodological issues raised by incorporating existing systematic reviews into complex reviews.
Ann Intern Med. 2008;148(10):776-782. doi:10.7326/0003-4819-148-10-200805200-00010
Lawrence S. Phillips, MD; Jennifer G. Twombly, MD, PhD
When blood pressure levels are above goal, clinicians often fail to intensify therapy—a practice called clinical inertia. Two recent Annals articles, one in this issue, provide information about the factors that contribute to clinical inertia in hypertension management. The studies suggest that clinical uncertainty about a patient's true blood pressure is a more important cause of clinical inertia than many comorbid conditions that require attention in a 15-minute visit. Clinicians will need a new paradigm to guide them in treating high blood pressure—it's time to overcome clinical inertia.
Ann Intern Med. 2008;148(10):783-785. doi:10.7326/0003-4819-148-10-200805200-00011
John E. Cornell, PhD, Associate Editor; Christine Laine, MD, MPH, Senior Deputy Editor
Annals has witnessed an increase in the frequency of “complex systematic overviews”—systematic reviews that use previous systematic reviews to construct an evidence base. Although using past systematic reviews can shorten the time required to produce an updated systematic review, complex systematic overviews present challenges. Cornell and Laine describe those challenges and provide suggestions for overcoming them.
Ann Intern Med. 2008;148(10):786-788. doi:10.7326/0003-4819-148-10-200805200-00012
Harold C. Sox, MD, Editor
This issue marks the marriage of 2 publications with large and loyal readerships—Annals of Internal Medicine and ACP Journal Club. Beginning today, ACP Journal Club will appear in the second of the 2 monthly issues of Annals.
Ann Intern Med. 2008;148(10):788. doi:10.7326/0003-4819-148-10-200805200-00013
Ann Intern Med. 2008;148(10):789-790. doi:10.7326/0003-4819-148-10-200805200-00014
Ann Intern Med. 2008;148(10):790-791. doi:10.7326/0003-4819-148-10-200805200-00015
Ann Intern Med. 2008;148(10):791-792. doi:10.7326/0003-4819-148-10-200805200-00016
Ann Intern Med. 2008;148(10):792-794. doi:10.7326/0003-4819-148-10-200805200-00017
Ann Intern Med. 2008;148(10):794-795. doi:10.7326/0003-4819-148-10-200805200-00018
Ann Intern Med. 2008;148(10):795. doi:10.7326/0003-4819-148-10-200805200-00019
Jennifer Fisher Wilson
Ann Intern Med. 2008;148(10):797-800. doi:10.7326/0003-4819-148-10-200805200-00022
R. Brian Haynes, MD, PhD, MACP
Ann Intern Med. 2008;148(10):JC3-2. doi:10.7326/0003-4819-148-10-200805200-02002
Daniel Sontheimer, MD, MBA
Ann Intern Med. 2008;148(10):JC3-3. doi:10.7326/0003-4819-148-10-200805200-02003
Eef Hogervorst, PhD
Ann Intern Med. 2008;148(10):JC3-4. doi:10.7326/0003-4819-148-10-200805200-02004
Bruce M. Rothschild, MD
Ann Intern Med. 2008;148(10):JC3-5. doi:10.7326/0003-4819-148-10-200805200-02005
Ronald L. Koretz, MD
Ann Intern Med. 2008;148(10):JC3-6. doi:10.7326/0003-4819-148-10-200805200-02006
Philip S. Wells, MD
Ann Intern Med. 2008;148(10):JC3-7. doi:10.7326/0003-4819-148-10-200805200-02007
James Shaw, MD, MPH
Ann Intern Med. 2008;148(10):JC3-8. doi:10.7326/0003-4819-148-10-200805200-02008
Shirin Shafazand, MD, MS, FCCP, D.ABSM, FRCP(C)
Ann Intern Med. 2008;148(10):JC3-9. doi:10.7326/0003-4819-148-10-200805200-02009
Jacob Korula, MD, FRCPC, FACP
Ann Intern Med. 2008;148(10):JC3-10. doi:10.7326/0003-4819-148-10-200805200-02010
Anna Peeters, PhD
Ann Intern Med. 2008;148(10):JC3-11. doi:10.7326/0003-4819-148-10-200805200-02011
Ann Intern Med. 2008;148(10):JC3-12. doi:10.7326/0003-4819-148-10-200805200-02012
Ann Intern Med. 2008;148(10):JC3-13. doi:10.7326/0003-4819-148-10-200805200-02013
Dena E. Rifkin, MD; Mark J. Sarnak, MD, MS
Ann Intern Med. 2008;148(10):JC3-14. doi:10.7326/0003-4819-148-10-200805200-02014
Ann Intern Med. 2008;148(10):I-46. doi:10.7326/0003-4819-148-10-200805200-00001
Ann Intern Med. 2008;148(10):I-53. doi:10.7326/0003-4819-148-10-200805200-00002
Ann Intern Med. 2008;148(10):I-60. doi:10.7326/0003-4819-148-10-200805200-00003
Johanna T. Dwyer, DSc, RD; Jean Mayer, USDA
Ann Intern Med. 2008;148(10):796. doi:10.7326/0003-4819-148-10-200805200-00020
Bernard M. Dickens, PhD, LLD
Ann Intern Med. 2008;148(10):796. doi:10.7326/0003-4819-148-10-200805200-00021
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only